Spatial arrangement of the modifications

Industry

CPC
C12N2310/34

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2310/00Structure or type of the nucleic acid

Current Industry

C12N2310/34Spatial arrangement of the modifications

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Gapmer antisense oligonucleotides targeting SARS-CoV-2 for treating...
- Patent number 12,163,132
- Issue date Dec 10, 2024
- Children's National Medical Center
- Yi-Wen Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides to restore dysferlin protein expression...
- Patent number 12,163,129
- Issue date Dec 10, 2024
- University of Massachusetts
- Robert H. Brown
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for modulating neuronal excitability and m...
- Patent number 12,163,130
- Issue date Dec 10, 2024
- Icahn School of Medicine at Mount Sinai
- Anne Schaefer
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Oligonucleotides for modulating Tau expression
- Patent number 12,163,131
- Issue date Dec 10, 2024
- HOFFMANN-LA ROCHE INC.
- Peter Hagedorn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulating the cellular stress response
- Patent number 12,157,888
- Issue date Dec 3, 2024
- The General Hospital Corporation
- Jeannie T. Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulators of MALAT1 expression
- Patent number 12,157,890
- Issue date Dec 3, 2024
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Selective antisense compounds and uses thereof
- Patent number 12,152,244
- Issue date Nov 26, 2024
- Ionis Pharmaceuticals, Inc.
- Michael Oestergaard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeting human satellite II (HSATII)
- Patent number 12,152,241
- Issue date Nov 26, 2024
- The General Hospital Corporation
- David T. Ting
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic compositions for treating pain via multiple targets
- Patent number 12,152,243
- Issue date Nov 26, 2024
- QUELLTX, INC.
- Graham T. Dempsey
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for the treatment of Leber congenital am...
- Patent number 12,139,711
- Issue date Nov 12, 2024
- STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
- Robert Wilhelmus Johanna Collin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for targeting pain directed at metabolic pathways
- Patent number 12,128,062
- Issue date Oct 29, 2024
- University of Maryland, Baltimore
- Ohannes Kevork Melemedjian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for modulating UBE3A-ATS
- Patent number 12,129,466
- Issue date Oct 29, 2024
- Ionis Pharmaceuticals, Inc.
- Paymaan Jafar-nejad
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Base editing of ANGPTL3 and methods of using same for treatment of...
- Patent number 12,115,230
- Issue date Oct 15, 2024
- Verve Therapeutics, Inc.
- Alexandra Chadwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for modulating SCN9A expression
- Patent number 12,116,576
- Issue date Oct 15, 2024
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Selective reduction of allelic variants
- Patent number 12,110,491
- Issue date Oct 8, 2024
- Ionis Pharmaceuticals, Inc.
- C. Frank Bennett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotide for targeting progranulin
- Patent number 12,104,153
- Issue date Oct 1, 2024
- HOFFMANN-LA ROCHE INC.
- Ravi Jagasia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PIKFYVE antisense oligonucleotides
- Patent number 12,104,159
- Issue date Oct 1, 2024
- ACURASTEM INCORPORATED
- Wen-Hsuan Chang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions for modulating tau expression
- Patent number 12,091,662
- Issue date Sep 17, 2024
- Biogen MA Inc.
- Holly Kordasiewicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid, composition and conjugate comprising the same, and pr...
- Patent number 12,084,661
- Issue date Sep 10, 2024
- Suzhou Ribo Life Science Co., Ltd.
- Hongyan Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified oligonucleotides and methods of use
- Patent number 12,077,757
- Issue date Sep 3, 2024
- JANSSEN PHARMACEUTICA NV
- Sergei Gryaznov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
SERPINA1 iRNA compositions and methods of use thereof
- Patent number 12,071,619
- Issue date Aug 27, 2024
- Alnylam Pharmaceuticals, Inc.
- Alfica Sehgal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulatory polynucleotides
- Patent number 12,071,625
- Issue date Aug 27, 2024
- VOYAGER THERAPEUTICS, INC.
- Jinzhao Hou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeting enhancer RNAs for the treatment of primary brain tumors
- Patent number 12,060,557
- Issue date Aug 13, 2024
- Brown University
- Nikolaos Tapinos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi agents for inhibiting expression of PNPLA3, pharmaceutical com...
- Patent number 12,054,718
- Issue date Aug 6, 2024
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for ordered and continuous complementary D...
- Patent number 12,054,705
- Issue date Aug 6, 2024
- The Regents of the University of California
- Kathleen Collins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids for inhibiting expression of LPA in a cell
- Patent number 12,054,717
- Issue date Aug 6, 2024
- Silence Therapeutics GmbH
- Sibylle Dames
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for the treatment of Stargardt disease
- Patent number 12,054,716
- Issue date Aug 6, 2024
- Stichting Katholieke Universiteit
- Robert Wilhelmus Johanna Collin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Two-tailed self-delivering siRNA
- Patent number 12,049,627
- Issue date Jul 30, 2024
- University of Massachusetts
- Anastasia Khvorova
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Transthyretin (TTR) iRNA compositions and methods of use thereof fo...
- Patent number 12,049,628
- Issue date Jul 30, 2024
- Alnylam Pharmaceuticals, Inc.
- Tracy Zimmermann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulation of alpha synuclein expression
- Patent number 12,043,831
- Issue date Jul 23, 2024
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
RNAi TARGETING KIF1A MISSENSE MUTATIONS FOR TREATMENT OF KIF1A ASSO...
- Publication number 20240409936
- Publication date Dec 12, 2024
- Ovid Therapeutics Inc.
- Noelle Germain
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi TARGETING PPP2R5D MISSENSE MUTATIONS FOR TREATMENT OF JORDAN’S...
- Publication number 20240409945
- Publication date Dec 12, 2024
- Ovid Therapeutics Inc.
- Noelle Germain
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PREVENTIVE OR THERAPEUTIC AGENT FOR BENIGN ADULT FAMILIAL MYOCLONIC...
- Publication number 20240409926
- Publication date Dec 12, 2024
- RIKEN
- Haruhisa INOUE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED DOUBLE-STRANDED RNA AGENTS
- Publication number 20240409942
- Publication date Dec 12, 2024
- Alnylam Pharmaceuticals, Inc.
- Martin MAIER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRES...
- Publication number 20240401038
- Publication date Dec 5, 2024
- Ionis Pharmaceuticals, Inc.
- Thazha P. Prakash
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION
- Publication number 20240401054
- Publication date Dec 5, 2024
- Ionis Pharmaceuticals, Inc.
- Thazha P. Prakash
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction
- Publication number 20240401034
- Publication date Dec 5, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Matthew H. Porteus
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compounds and Methods for Reducing ATXN2 Expression
- Publication number 20240401039
- Publication date Dec 5, 2024
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BASE EDITING OF PCSK9 AND METHODS OF USING SAME FOR TREATMENT OF DI...
- Publication number 20240390523
- Publication date Nov 28, 2024
- Verve Therapeutics, Inc.
- Alexandra Chadwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
C5a Binding Nucleic Acids
- Publication number 20240384275
- Publication date Nov 21, 2024
- Aptarion Biotech AG
- Kai Hohlig
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oligonucleotides
- Publication number 20240384268
- Publication date Nov 21, 2024
- Hudson Institute of Medical Research
- Michael Paul Marie Gantier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20240376477
- Publication date Nov 14, 2024
- Alnylam Pharmaceuticals, Inc.
- Anna Borodovsky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Selective Antisense Compounds and Uses Thereof
- Publication number 20240368592
- Publication date Nov 7, 2024
- Ionis Pharmaceuticals, Inc.
- Punit P. Seth
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEO...
- Publication number 20240368593
- Publication date Nov 7, 2024
- Roche Innovation Center Copenhagen A/S
- Konrad Bleicher
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES COMPRISING SEGMENTED GAP STRUCTURES
- Publication number 20240368602
- Publication date Nov 7, 2024
- AUSPERBIO THERAPEUTICS INC.
- Guofeng CHENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDE THERAPY FOR H3.3 K27M DIFFUSE MIDLINE GLI...
- Publication number 20240360450
- Publication date Oct 31, 2024
- COLD SPRING HARBOR HARBOR LABORATORY
- Adrian Krainer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOL...
- Publication number 20240360452
- Publication date Oct 31, 2024
- BioMarin Technologies B.V.
- Judith Christina Theodora Van Deutekom
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compounds and Methods for Reducing LRRK2 Expression
- Publication number 20240360453
- Publication date Oct 31, 2024
- Ionis Pharmaceuticals, Inc.
- Tracy A. Cole
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
- Publication number 20240360448
- Publication date Oct 31, 2024
- Ionis Pharmaceuticals, Inc.
- Hans-Joachim Josef Gaus
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE INHIBITORS OF MIR17HG PRE-RNA AS THERAPEUTIC AGENTS IN CA...
- Publication number 20240352462
- Publication date Oct 24, 2024
- Dana-Farber Cancer Institute, Inc.
- Nikhil C. Munshi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN (a) EXPRESSION
- Publication number 20240352455
- Publication date Oct 24, 2024
- Ionis Pharmaceuticals, Inc.
- Thazha P. Prakash
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and methods for ordered and continuous complementary D...
- Publication number 20240344050
- Publication date Oct 17, 2024
- The Regents of the University of California
- Kathleen Collins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and methods for ordered and continuous complementary D...
- Publication number 20240344051
- Publication date Oct 17, 2024
- The Regents of the University of California
- Kathleen Collins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT FOR TYROSINE DEGRADATION-ASSOCIATED DISORDERS
- Publication number 20240344072
- Publication date Oct 17, 2024
- UCL Business LTD
- Haiyan Zhou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODULATION OF GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES T...
- Publication number 20240336924
- Publication date Oct 10, 2024
- CAMP4 THERAPEUTICS CORPORATION
- Alfica Sehgal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modification of 3' Terminal Ends of Nucleic Acids by DNA Polymerase...
- Publication number 20240336901
- Publication date Oct 10, 2024
- Richard T. Pomerantz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF
- Publication number 20240336920
- Publication date Oct 10, 2024
- HOFFMANN-LA ROCHE INC.
- Jessica Marine Aurore BASTIEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODULATORS OF ENaC EXPRESSION
- Publication number 20240327838
- Publication date Oct 3, 2024
- Ionis Pharmaceuticals, Inc.
- Jeffrey R. Crosby
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL
- Publication number 20240327843
- Publication date Oct 3, 2024
- Silence Therapeutics GMBH
- Sibylle Dames
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING UNC13A
- Publication number 20240327845
- Publication date Oct 3, 2024
- HOFFMANN-LA ROCHE INC.
- Katarzyna Chyzynska
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Spatial arrangement of the modifications

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Gapmer antisense oligonucleotides targeting SARS-CoV-2 for treating...

Antisense oligonucleotides to restore dysferlin protein expression...

Compositions and methods for modulating neuronal excitability and m...

Oligonucleotides for modulating Tau expression

Modulating the cellular stress response

Modulators of MALAT1 expression

Selective antisense compounds and uses thereof

Targeting human satellite II (HSATII)

Therapeutic compositions for treating pain via multiple targets

Antisense oligonucleotides for the treatment of Leber congenital am...

Methods for targeting pain directed at metabolic pathways

Compounds and methods for modulating UBE3A-ATS

Base editing of ANGPTL3 and methods of using same for treatment of...

Oligonucleotides for modulating SCN9A expression

Selective reduction of allelic variants

Antisense oligonucleotide for targeting progranulin

PIKFYVE antisense oligonucleotides

Compositions for modulating tau expression

Nucleic acid, composition and conjugate comprising the same, and pr...

Modified oligonucleotides and methods of use

SERPINA1 iRNA compositions and methods of use thereof

Modulatory polynucleotides

Targeting enhancer RNAs for the treatment of primary brain tumors

RNAi agents for inhibiting expression of PNPLA3, pharmaceutical com...

Compositions and methods for ordered and continuous complementary D...

Nucleic acids for inhibiting expression of LPA in a cell

Antisense oligonucleotides for the treatment of Stargardt disease

Two-tailed self-delivering siRNA

Transthyretin (TTR) iRNA compositions and methods of use thereof fo...

Modulation of alpha synuclein expression

Patents Applicationslast 30 patents

RNAi TARGETING KIF1A MISSENSE MUTATIONS FOR TREATMENT OF KIF1A ASSO...

RNAi TARGETING PPP2R5D MISSENSE MUTATIONS FOR TREATMENT OF JORDAN’S...

PREVENTIVE OR THERAPEUTIC AGENT FOR BENIGN ADULT FAMILIAL MYOCLONIC...

MODIFIED DOUBLE-STRANDED RNA AGENTS

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRES...

COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION

Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction

Compounds and Methods for Reducing ATXN2 Expression

BASE EDITING OF PCSK9 AND METHODS OF USING SAME FOR TREATMENT OF DI...

C5a Binding Nucleic Acids

Oligonucleotides

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Selective Antisense Compounds and Uses Thereof

GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEO...

OLIGONUCLEOTIDES COMPRISING SEGMENTED GAP STRUCTURES

ANTISENSE OLIGONUCLEOTIDE THERAPY FOR H3.3 K27M DIFFUSE MIDLINE GLI...

METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOL...

Compounds and Methods for Reducing LRRK2 Expression

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

ANTISENSE INHIBITORS OF MIR17HG PRE-RNA AS THERAPEUTIC AGENTS IN CA...

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN (a) EXPRESSION

Compositions and methods for ordered and continuous complementary D...

Compositions and methods for ordered and continuous complementary D...

TREATMENT FOR TYROSINE DEGRADATION-ASSOCIATED DISORDERS

MODULATION OF GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES T...

Modification of 3' Terminal Ends of Nucleic Acids by DNA Polymerase...

THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF

MODULATORS OF ENaC EXPRESSION

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

ANTISENSE OLIGONUCLEOTIDES TARGETING UNC13A